The Uromigos Episode 157: ASCO GU 2022 Sacituzumab and Pembrolizumab in Bladder Cancer
Dr Petros Grivas describes the results of the phase 2 trial of sacituzumab and pembrolizumab in bladder cancer presented at the 2022 ASCO GU Symposium.
670 Madison Ave.
Manalapan, NJ 07726
Contributors and Partners
Cancer Nursing Today
Urban Health Today
Blood Cancers Today
© 2022 Mashup Media, LLC. All rights reserved.